Find link

language:

Find link is a tool written by Edward Betts.

searching for Natalizumab 10 found (47 total)

Integrin alpha 4 (1,210 words) [view diff] exact match in snippet view article find links to article

1600-065X.2002.18611.x. PMID 12234367. S2CID 37850994. O'Connor P (2007). "Natalizumab and the role of alpha 4-integrin antagonism in the treatment of multiple

Igor J. Koralnik (2,387 words) [view diff] exact match in snippet view article find links to article

patients with MS who have been treated with natalizumab (Tysabri) or dimethylfumarate (Tecfidera). Natalizumab, an immuno-modulatory medication, was associated

LPAM-1 (1,246 words) [view diff] exact match in snippet view article find links to article

colitis, the expression of MAdCAM-1 is increased in inflamed mucosa. Natalizumab (anti-α4) is a humanized IgG4 monoclonal antibody that targets α4 subunit

Helminthic therapy (3,486 words) [view diff] exact match in snippet view article find links to article

relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab". BMC Neurology. 12: 95. doi:10.1186/1471-2377-12-95. PMC 3517482. PMID 22989378

Joseph Berger (neurologist) (878 words) [view diff] exact match in snippet view article

"Progressive multifocal leukoencephalopathy: Lessons from AIDS and natalizumab". Neurological Research. 28 (3): 299–305. doi:10.1179/016164106X98198

CCL17 (3,871 words) [view diff] exact match in snippet view article find links to article

therefore likely candidates for study and therapy. Treatments of MS (such as natalizumab or methylprednisolone) seem to lower overall chemokine levels (notably

Antibody (13,287 words) [view diff] exact match in snippet view article find links to article

1146/annurev.immunol.19.1.163. PMID 11244034. Doggrell SA (June 2003). "Is natalizumab a breakthrough in the treatment of multiple sclerosis?". Expert Opinion

Michael Bonney (1,679 words) [view diff] exact match in snippet view article find links to article

of Biogen's clinical development review board "for the development of natalizumab for treating multiple sclerosis, Crohn's disease, and rheumatoid arthritis

Heinz Wiendl (1,863 words) [view diff] exact match in snippet view article find links to article

Wiendl H. L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients. Neurology. 2013;81:865-71 Kappos L, Wiendl H, Selmaj

Biomarkers of multiple sclerosis (7,797 words) [view diff] exact match in snippet view article find links to article

example could be the Hellberg-Eklund score for predicting the response to Natalizumab. Though biomarkers are normally assumed to be chemical compounds in body